pyrroles has been researched along with Pituitary Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Dou, G; Hu, F; Jiang, S; Li, J; Li, Y; Sheng, C; Wang, X; Wu, B; Zhang, Y; Zhao, G; Zhong, S | 1 |
Cohen, O; Cohen, ZR; Gorshtein, A; Hadani, M; Kammer, A; Rubinfeld, H; Shimon, I; Werner, H | 1 |
Payandeh, M; Sadeghi, E; Sadeghi, M | 1 |
Campitiello, M; Eid, N; Hennequin, L; Longo, R; Plastino, F; Quétin, P; Wendel, C | 1 |
4 other study(ies) available for pyrroles and Pituitary Neoplasms
Article | Year |
---|---|
T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma.
Topics: Antineoplastic Agents; Benzophenones; Cell Line; Gene Expression Regulation; Gene Regulatory Networks; Humans; Isoxazoles; Oligonucleotide Array Sequence Analysis; Pituitary Gland; Pituitary Neoplasms; Pyrimidines; Pyrroles | 2019 |
IGF1 induces cell proliferation in human pituitary tumors - functional blockade of IGF1 receptor as a novel therapeutic approach in non-functioning tumors.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin D3; Female; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Pituitary Neoplasms; Protein Processing, Post-Translational; Pyrimidines; Pyrroles; Rats | 2014 |
The Complete Response to Targeted Drugs Without Surgery or Radiotherapy: A Case of Pituitary Metastasis From Renal Cell Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Diabetes Insipidus; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Pyrroles; Sunitinib | 2016 |
Pituitary Metastasis from Renal Cell Carcinoma: Description of a Case Report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Axitinib; Carcinoma, Renal Cell; Disease Progression; Everolimus; Humans; Imidazoles; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Neurosurgical Procedures; Niacinamide; Phenylurea Compounds; Pituitary Neoplasms; Pyrroles; Radiotherapy, Adjuvant; Sorafenib; Sunitinib; Treatment Outcome | 2017 |